Holdings
Bain Capital Life Sciences Investors, LLC
As of Sep 30, 2026, Bain Capital Life Sciences Investors, LLC reported 19 positions worth US$1.19B. Largest: Kailera Therapeutics, Inc., Heartflow, Inc. and ADARx Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kailera Therapeutics, Inc. | 22.6M | US$258M | no change | Sep 30, 2026 |
| Heartflow, Inc. | 4.45M | US$221M | −4M | Sep 30, 2026 |
| ADARx Pharmaceuticals, Inc. | 6.73M | US$134M | new | Sep 30, 2026 |
| Savara, Inc. | 17.6M | US$90.8M | no change | Sep 30, 2026 |
| Tarsus Pharmaceuticals, Inc. | 1.1M | US$86.2M | new | Sep 30, 2026 |
| Solid Biosciences Inc. | 9.81M | US$70.9M | no change | Sep 30, 2026 |
| Olema Pharmaceuticals, Inc. | 7.09M | US$61.2M | no change | Sep 30, 2026 |
| Hemab Therapeutics Holdings, Inc. | 1.65M | US$50.9M | no change | Sep 30, 2026 |
| Cabaletta Bio, Inc. | 21.2M | US$40.7M | +3.97M | Sep 30, 2026 |
| Freenome, Inc. | 2.37M | US$37.3M | new | Sep 30, 2026 |